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Research
Numerous studies have consistently found a 
significant association between fine particu­
late matter ≤ 2.5 µm in aerodynamic diameter 
(PM2.5) air pollution and the short­term risk of 
clinical cardiovascular mortality (Franklin et al. 
2007, 2008; Ostro et al. 2006; Zanobetti and 
Schwartz 2009). The mechanisms responsible 
for such an association have been the focus of 
recent environmental health studies. In popula­
tion­based studies of healthy individuals (Dekker 
et al. 1994; Goldberg et al. 1991; Peters et al. 
1990; Rautaharju et al. 2006a, 2006b; Schouten 
et al. 1991), longer repolarization within normal 
range was significantly associated with cardiac 
events, especially sudden cardiac death. Similar 
findings from clinical populations (Siscovick 
et al. 1996; Whitsel et al. 2000, 2001) have also 
been reported. Recent studies have suggested 
that one of the underlying mechanisms linking 
air pollution and increased risk of cardiovascular 
disease (CVD) is the effect of PM on ventricular 
repolarization (Campen et al. 2006; Ghelfi et al. 
2008; Henneberger et al. 2005; Lux and Pope 
2009; Samet et al. 2009; Yue et al. 2007). For 
the time course of PM effects on cardiac elec­
trophysiology, several published studies have 
suggested shorter time effects, such as within the 
same day or 1–2 days prior to electrocardiogram 
(ECG) measurements (Elder et al. 2007; Liao 
et al. 1999, 2004, 2009; Lux and Pope 2009; 
Park et al. 2005; Yue et al. 2007; Zanobetti 
et al. 2009; Zhang et al. 2009). For patients 
who wore implanted cardioverter defibrillators, 
Dockery et al. (2005) reported significantly 
increased incidence of arrhythmias associated 
with the 2­day average of various pollutants, 
which also suggested acute effects of pollution 
on clinically relevant arrhythmias. In one study 
specifically designed to investigate the time 
course of PM on heart rate variability (HRV), 
Cavallari et al. (2008) reported an early­ and a 
later­phase response, with the early effects at 2 
hr and delayed effects at 9–13 hr after exposure.
We therefore designed this study to 
investigate the effects and time course of 
individual­level exposures to PM2.5 on the 
ventricular repolarization in a sample of non­
smoking adults who lived in communities in 
central Pennsylvania.
Materials and Methods
Population. For this report, we used the data 
collected for the Air Pollution and Cardiac 
Risk and its Time Course (APACR) study, 
which we designed to investigate the mecha­
nisms and the time course of the adverse 
effects of PM2.5 on cardiac electro  physiology, 
blood coagulation, and systemic inflam­
mation. The APACR study has maintained 
approval by Penn State University College of 
Medicine institutional review board. All par­
ticipants gave written informed consent prior 
to their participation in the study. All study 
participants were recruited from communi­
ties in central Pennsylvania, mostly from the 
Harrisburg metropolitan area. The inclusion 
criteria for the study included nonsmoking 
adults > 45 years old who had not been diag­
nosed with severe cardiac problems (defined 
as diagnosed valvular heart disease, congenital 
heart disease, acute myocardial infarction or 
stroke within 6 months, or congestive heart 
failure). Community recruitment specialists 
from the General Clinical Research Center 
(GCRC), which is funded by the National 
Institutes of Health, at the Penn State College 
of Medicine, and the GCRC­organized com­
munity outreach activities, supported the 
recruitment of the participants. The GCRC 
maintains a list of individuals who live in cen­
tral Pennsylvania communities for various 
health­related studies. The APACR study par­
ticipants were numerated from the GCRC’s 
list of potential participants; approximately 
75% of the individuals who were contacted 
and who met our inclusion criteria were 
enrolled in the study. Our targeted sample 
size was 100 individuals, and we enrolled and 
examined 106 individuals. The examination of 
two participants per week was conducted from 
November 2007 to June 2009 for the entire 
examination period except for major holidays.
Study participants were examined in the 
GCRC in the morning between 0800 and 
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Ba c k g r o u n d: The mechanisms for the relationship between particulate pollution and cardiac 
  disease are not fully understood.
oB j e c t i v e: We examined the effects and time course of exposure to fine particulate matter ≤ 2.5 µm 
in aerodynamic diameter (PM2.5) on ventricular repolarization of 106 nonsmoking adults who were 
living in communities in central Pennsylvania.
Me t h o d s : The 24­hr beat­to­beat electrocardiogram (ECG) data were obtained using a high­
resolution 12­lead Holter system. After visually identifying and removing artifacts and arrhythmic 
beats, we summarized normal beat­to­beat QTs from each 30­min segment as heart rate (HR)­
corrected QT measures: QT prolongation index (QTI), Bazett’s HR­corrected QT (QTcB), and 
Fridericia’s HR­corrected QT (QTcF). A personal PM2.5 monitor was used to measure individual­
level real­time PM2.5 exposures for 24 hr. We averaged these data and used 30­min time­specific 
average PM2.5 exposures.
re s u l t s: The mean age of the participants was 56 ± 8 years, with 41% male and 74% white. The 
means ± SDs for QTI, QTcB, and QTcF were 111 ± 6.6, 438 ± 23 msec, and 422 ± 22 msec, 
respectively; and for PM2.5, the mean ± SD was 14 ± 22 µg/m3. We used distributed lag models 
under a framework of linear mixed­effects models to assess the autocorrelation­corrected regression 
coefficients (β) between 30­min PM2.5 and the HR­corrected QT measures. Most of the adverse 
ventricular repolarization effects from PM2.5 exposure occurred within 3–4 hr. The multivariable 
adjusted β (SE, p­value) due to a 10­µg/m3 increase in lag 7 PM2.5 on QTI, QTcB, and QTcF were 
0.08 (0.04, p < 0.05), 0.22 (0.08, p < 0.01), and 0.09 (0.05, p < 0.05), respectively.
co n c l u s i o n s: Our results suggest a significant adverse effect of PM2.5 on ventricular repolarization. 
The time course of the effect is within 3–4 hr of elevated PM2.5.
key w o r d s : autonomic modulation, cardiovascular disease, particulate matter, QT interval, ven­
tricular repolarization. Environ Health Perspect 118:1010–1015 (2010).  doi:10.1289/ehp.0901648 
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1000 hours. All participants fasted for at least 
8 hr before the clinical examination. After 
completing a health history questionnaire, a 
trained research nurse measured seated blood 
pressure (BP) three times, height, and weight, 
and drew 50 mL blood for biomarker assays 
according to the blood sample preparation 
protocols. A trained investigator connected the 
PM2.5 and Holter ECG recorders. Participants 
were given an hourly activity log to record 
special events that occurred in the next 24 hr, 
including outdoor activities, exposure to traf­
fic on the street, travel in an automobile, and 
any physical activities. The entire examination 
session lasted for about 1 hr. Participants were 
then released to proceed with their usual daily 
routines. The next morning, they returned 
to the GCRC to remove the PM and Holter 
monitors, to deliver the completed activity log, 
and to have their seated BP measured three 
times and another 50 mL of blood drawn. An 
exercise echocardiogram was then performed 
to measure the ventricular function and struc­
ture for each participant. The entire second 
day session lasted for about 1 hr and 45 min. 
A description of the participants’ characteris­
tics are presented in Table 1.
The study protocol was approved by Penn 
State University College of Medicine institu­
tional review board. Each participant received 
$50 and two certificates for breakfast in the 
hospital cafeteria, and they were reimbursed 
for their transportation costs.
PM2.5 concentration.  The APACR 
study used personal PM2.5 DataRam (pDR; 
Thromo Scientific, Boston, MA) for real­time 
24­hr personal PM2.5 exposure assessment. 
The pDR used light­scattering physics of 
the fine particles to detect the real­time con­
centrations of particles of various sizes. The 
size selection was achieved by using an active 
pump with a validated size­selection cyclone 
inlet (KTL SCC1.062; BGI Inc., Waltham, 
MA) at a flow rate of 1.5 L/min. The stan­
dardized operation procedures (SOP) for the 
use of the pDR, including the calibration, 
application, data transfer, and data validation, 
as well as chemical analysis of filters for major 
PM2.5 species, were developed by the APACR 
investigators (Penn State University 2008a). 
The standardized procedures were rigorously 
followed in the PM2.5 data collection. The 
real­time PM2.5 concentrations were initially 
recorded at 1­min intervals. For each par­
ticipant, we calculated the 30­min segment­
specific averages, based on the top and the 
bottom of the clock time, as our PM2.5 expo­
sure variable in the APACR study. Therefore, 
the PM2.5 exposure variables were treated as 
repeated measures, and each individual con­
tributed 48 exposure data points.
Continuous ambulatory ECG. A high­
fidelity (sampling frequency 1,000 Hz) 12­lead   
HScribe Holter System (Mortara Instrument, 
Inc., Milwaukee, WI) was used to collect the 
24­hr Holter beat­to­beat ECG data. The 
high­fidelity ECG significantly increases the 
resolution and enhances the accuracy of vari­
ous wave form measurements. The Holter 
ECG data were scanned to a designated com­
puter for offline processing by an experienced 
investigator using specialized SuperECG soft­
ware (Mortara Instrument, Inc.). The SOPs 
for the APACR study were developed by the 
study investigators (Penn State University 
2008b, 2008c) and were rigorously fol­
lowed in the data collection and interpreta­
tion processes. Briefly, the Holter ECG Data 
Collection and Analysis Procedures (Penn 
State University 2008b) were followed to pre­
pare, hook up, calibrate, and start the Holter 
digital recorder. After 24 hr of recording, 
a trained investigator followed the SOP to 
retrieve and archive the beat­to­beat ECG 
data for offline processing. The main objec­
tive of the offline processing was to verify the 
Holter­identified ECG waves and to iden­
tify and label additional electronic artifacts 
and arrhythmic beats in the ECG recording. 
Finally, a single research investigator followed 
the SuperECG Manual (Penn State University 
2008c) to perform beat­to­beat ECG analysis 
to calculate ECG parameters.
QT interval and QRS duration variables. 
We used the above described 24­hr beat­to­
beat Holter ECG, after removing artifacts 
with standardized visional inspection and sta­
tistical filters, to calculate beat­to­beat QT 
intervals using the SuperECG software, which 
defined QT interval as the start of Q wave 
to the end of T wave. None of the normal 
sinus QRS durations was > 120 msec. QT 
is heart rate (HR) dependent, and only after 
HR correction does the QT interval have 
the electrophysiological property of ventricu­
lar repolarization. We then calculated the 
following three HR­corrected QT duration 
indices as the measures of ventricular repolari­
zation on a 30­min basis.
•	Prolongation	index	(QTI)	=	100	× 
(QTmax ÷ QTpredicted), where QTmax is 
the maximum QT duration across all 
normal cardiac cycles within the segment 
and QTpredicted = 656 ÷ (1 + 0.01 × HR) 
(Rautaharju et al. 1991).
•	Bazett’s	HR­corrected QT interval (QTcB) 
(Bazett 1920) = QT ÷ √
– R — R.
•	Fridericia’s HR­corrected QT interval 
(QTcF) (Fridericia 2002) = QT ÷ 
3
√
– R — R.
These HR­corrected indices were chosen 
because the QTI has been reported to be 
(Rautaharju et al. 1991) less rate sensitive and 
because it has a higher rate of repeatability than 
does QTcB, which is the first HR­correction 
QT index; QTcF has similar properties but 
better HR correction compared with QTcB. 
These ECG measures were treated as repeated 
outcome measures, and each individual con­
tributed 48 outcome data points on each of the 
three ventricular repolarization variables.
The QRS duration (QRS) was calculated 
as the duration from the start of Q wave to 
the end of S wave. QRS duration was used as 
a measure of ventricular depolariation.
HRV variables. We performed time and 
frequency domain HRV analysis on the ECG 
recording after removing artifacts with stan­
dardized visional inspection and statistical fil­
ters. We calculated HRV indices from overall 
24­hr recording, 30­min, and 5­min segment­
specific recordings using the SuperECG pack­
age (Mortara Instrument, Inc.) according to 
the current recommendations (Task Force 
of the European Society of Cardiology and 
the North American Society of Pacing and 
Electrophysiology 1996). The following HRV 
indices were used as indices of cardiac auto­
nomic modulation: SD of all RR intervals 
Table 1. Demographic characteristics and health status of the study population.a
Hypertension, diabetes, or CVD
Characteristic
All subjects  
n =106
No  
n = 60
Yes  
n = 46
Age (years) 56 ± 7.6 56 ± 8.2 57 ± 6.8
Sex (% male) 41 40 41
Race (% white) 74 72 76
Glucose (mg/dL) 89 ± 25 85 ± 10 94 ± 36
Body mass index (kg/m2) 27.71 ± 5.86 26.19 ± 4.31 29.69 ± 6.98
History of coronary heart disease (%) 8.5 0.0 19.6
Hypertension (%) 35 0.0 85
Diabetes (%) 7.6 0.0 17.4
Systolic BP (mmHg) 122 ± 15.7 117 ± 11.9 128 ± 17.93
Diastolic BP (mmHg) 75 ± 9.2 73 ± 8.3 78 ± 9.8
College or higher education (%) 78 73 85
QTI 110.68 ± 6.60 109.98 ± 6.28 111.59 ± 6.90
QTcB (msec) 438.11 ± 23.34 435.33 ± 21.52 441.70 ± 25.05
QTcF (msec) 421.70 ± 21.55 419.44 ± 20.40 424.62 ± 22.62
QRS duration (msec) 93.97 ± 10.78 94.22 ± 10.49 93.65 ± 11.13
PM2.5 (µg/m3) 13.61 ± 21.59 11.86 ± 14.69 15.87 ± 27.95
Temperature (°C) 22 ± 3.5 22 ± 3.7 22 ± 3.4
Relative humidity (%) 40 ± 12.1 40 ± 12.3 39 ± 11.8
aResults represent means ± SD for continuous variables and percentage (%) for binary variables.Liao et al.
1012  v o l u m e  118 | n u m b e r 7 | July 2010  •  Environmental Health Perspectives
(SDNN, milliseconds), square root of the 
mean of the sum of the squares of differences 
between adjacent RR (RMSSD, msec), power 
in the low­frequency (LF) range (0.04–0.15 
Hz), power in the high frequency (HF) range 
(0.15–0.40 Hz), and the ratio of LF and HF.
Weather variables. We obtained real­
time temperature and relative humidity using 
the HOBO H8 logger (Onset Computer 
Corporation, Bourne, MA). The real­time 
temperature and relative humidity were 
recorded at 1­min intervals initially. For each 
participant, we calculated 30­min segment­
specific averages, corresponding to the PM2.5 
and Holter measures. Therefore, these weather 
covariables were treated as repeated measures, 
and each individual contributed 48 data points 
for each variable.
Other participant-level covariables. A 
standardized questionnaire administered on 
day 1 of the study was used to collect the fol­
lowing individual­level information: a) demo­
graphic variables, including age, race, sex, and 
highest education level; b) medication uses, 
including antianginal medication, antihyper­
tensive medication, and antidiabetic medi­
cation; and c) physician­diagnosed chronic 
disease history, including CVD (including 
revascularization procedures and myocardial 
infarction), hypertension, and diabetes. The 
averages of the second and third measures 
of seated systolic and diastolic BPs on day 
1 were used to represent BP levels of a par­
ticipant. Day 1 fasting glucose was measured 
by Penn State GCRC central laboratory. 
CVD was defined by antianginal medication 
use or a history of CVD. Hypertension was 
defined by antihypertensive medication use, 
physician­diagnosed hypertension, systolic BP 
≥ 140 mmHg, or diastolic BP ≥ 90 mmHg. 
Diabetes was defined by antidiabetic medica­
tion use, a diagnosis of diabetes by a physi­
cian, or fasting glucose > 126 mg/dL. Body 
mass index (BMI) was defined as the ratio of 
weight (kilograms) to height squared (meters).
Statistical analysis. We used distributed 
lag models (Almon 1965; Pope and Schwartz 
1996; Schwartz 2000) under a framework 
of linear mixed­effects models (Laird and 
Ware 1982) with a first­order autoregres­
sive covariance structure to assess the auto­
correlation corrected regression coefficients 
between 30­min PM2.5 and the HR­corrected 
QT measures. Residual diagnostics were 
used to assess the appropriateness of mod­
eling assumptions, and no sizeable depar­
tures were detected. In these models, one 
lag indicated a 30­min separation between 
the exposure and outcome. Thus, lag 0 indi­
cated the spontaneous relationships between 
PM2.5 and the HR­corrected QT measures, 
and lag 1 indicated 30 min between the 
PM2.5 and HR­corrected QT measures, and 
so on. Because QT interval includes QRS 
duration, with the latter mostly represent­
ing the ventricular depolarization process, 
we analyzed QRS interval in models identi­
cal to those for the QT variables. We chose 
a constrained distributed lag model, the 
polynomial distributed lag model, to reduce 
the potential collinearity of PM2.5 between 
individual lags using a second­degree poly­
nomial. Another advantage of the distributed 
lag model is its ability to provide interpre­
tation of the cumulative effects of the lags 
included in the model, as well as individual 
lag effects. Because the PM2.5 and ECG vari­
ables were assessed in parallel over 48 lags 
(24 hr), we predetermined to model no more 
than 10 lags, which allowed us to fit the dis­
tributed lag models using at least 80% of the 
data. We started from the largest number of 
lags (lag 0–lag 10), and identified significant 
(p < 0.05) cumulative effects of PM2.5 on the 
ECG variables. In this report, the cumulative 
effect on QTI was significant in the 10­lag 
model. From this 10­lag significant cumula­
tive­effect model, we reduced the total num­
ber of individual lags by back­eliminating the 
nonsignificant longer lags (e.g., lag 10), one 
lag at a time until a significant individual lag 
was identified (lag 7 in this report). We then 
identified this model as our final model for all 
ECG outcomes. All results were expressed per 
10­µg/m3 increase in PM2.5. The distributed 
lag models are summarized in Table 2, where 
model 1 was adjusted for basic demographic 
variables and model 2 included an additional 
adjustment for diabetes, hypertension, and 
CVD. We repeated model 2 by adjusting 
for each of the HRV variables to examine 
the impact of cardiac autonomic modula­
tion on PM2.5 and QT associations. These 
results are summarized in Table 3. In these 
models, all time­dependent covariables, such 
as weather and HRV variables, were entered 
in the model using the same distributed lag 
structure as the PM2.5 variable.
Table 3. Regression coefficient (SE) of HR-corrected QT measures associated with 10-µg/m3 increment of PM2.5 with additional adjustment for HRV variables.a
QTI QTcB (msec) QTcF (msec)
HF LF SDNN RMSSD HF LF SDNN RMSSD HF LF SDNN RMSSD
Lag 0 (same time) 0.08 (0.04)** 0.07 (0.04)** 0.09 (0.04)** 0.08 (0.04)** 0.05 (0.08) 0.05 (0.08) 0.07 (0.08) 0.05 (0.08) –0.05 (0.05) –0.05 (0.05) –0.05 (0.05) –0.05 (0.05)
Lag 1 (30 min) 0.04 (0.02)* 0.04 (0.02)* 0.04 (0.02)* 0.04 (0.02)* 0.01 (0.06) 0.01 (0.06) 0.02 (0.06) –0.01 (0.06) –0.04 (0.04) –0.04 (0.04) –0.04 (0.04) –0.04 (0.04)
Lag 2 (60 min) 0.01 (0.02) 0.01 (0.02) 0.01 (0.02) 0.02 (0.02) –0.01 (0.06) –0.01 (0.06) –0.01 (0.06) –0.03 (0.06) –0.02 (0.04) –0.02 (0.04) –0.02 (0.04) –0.03 (0.04)
Lag 3 (90 min) –0.001 (0.03) 0.001 (0.03) –0.01 (0.03) 0.01 (0.03) –0.003 (0.07) 0.0004 (0.07) –0.01 (0.07) –0.03 (0.06) 0.003 (0.04) 0.004 (0.04) –0.002 (0.04) –0.01 (0.04)
Lag 4 (120 min) –0.001 (0.03) 0.001 (0.03) –0.01 (0.03) 0.01 (0.03) 0.02 (0.07) 0.03 (0.07) 0.02 (0.07) –0.004 (0.07) 0.03 (0.04) 0.03 (0.04) 0.02 (0.04) 0.02 (0.04)
Lag 5 (150 min) 0.01 (0.03) 0.01 (0.03) 0.004 (0.03) 0.02 (0.03) 0.08 (0.07) 0.08 (0.07) 0.07 (0.07) 0.05 (0.07) 0.05 (0.04) 0.06 (0.04) 0.05 (0.04) 0.04 (0.04)
Lag 6 (180 min) 0.03 (0.03) 0.04 (0.03) 0.03 (0.03) 0.04 (0.03) 0.15 (0.07)** 0.15 (0.07)** 0.15 (0.07) ** 0.13 (0.07)** 0.08 (0.04)** 0.08 (0.04)** 0.08 (0.04)** 0.08 (0.04)*
Lag 7 (210 min) 0.07 (0.04)* 0.07 (0.04)* 0.07 (0.04)* 0.08 (0.04)* 0.25 (0.09)# 0.25 (0.09)# 0.25 (0.09)# 0.24 (0.09)# 0.12 (0.05)** 0.12 (0.05)** 0.12 (0.05)** 0.11 (0.05)**
Cumulative 0.24 (0.14)* 0.25 (0.14)* 0.23 (0.14)* 0.29 (0.13)** 0.56 (0.40) 0.57 (0.40) 0.56 (0.40) 0.39 (0.40) 0.17 (0.25) 0.18 (0.25) 0.17 (0.25) 0.11 (0.25)
aAdjusted for age, sex, race, temperature, relative humidity, diabetes, hypertension, CVD, and each of the HRV indices. *p < 0.1. **p < 0.05. #p < 0.01.
Table 2. Regression coefficient (SE) of HR- 
corrected QT measures associated with 10-µg/m3 
increment of PM2.5 concentration.
QT variable/Lags
Regression coefficient (SE)
Model 1a  Model 2b
QTI
Lag 0 (same time) 0.08 (0.04)* 0.07 (0.04)*
Lag 1 (30 min) 0.05 (0.02)* 0.04 (0.02)*
Lag 2 (60 min) 0.03 (0.04) 0.02 (0.02)
Lag 3 (90 min) 0.02 (0.03) 0.01 (0.03)
Lag 4 (120 min) 0.02 (0.03) 0.01 (0.03)
Lag 5 (150 min) 0.03 (0.02) 0.02 (0.02)
Lag 6 (180 min) 0.05 (0.03)* 0.05 (0.03)*
Lag 7 (210 min) 0.08 (0.04)* 0.08 (0.04)*
Cumulative 0.37 (0.13)** 0.32 (0.13)**
QTcB (msec)
Lag 0 (same time) 0.05 (0.08) 0.05 (0.08)
Lag 1 (30 min) 0.02 (0.06) 0.02 (0.06)
Lag 2 (60 min) 0.01 (0.06) 0.003 (0.06)
Lag 3 (90 min) 0.02 (0.07) 0.01 (0.07)
Lag 4 (120 min) 0.04 (0.07) 0.03 (0.07)
Lag 5 (150 min) 0.08 (0.06) 0.08 (0.06)
Lag 6 (180 min) 0.14 (0.06)* 0.14 (0.06)*
Lag 7 (210 min) 0.22 (0.09)** 0.22 (0.08)**
Cumulative 0.59 (0.39) 0.54 (0.39)
QTcF (msec)
Lag 0 (same time) –0.05 (0.05) –0.05 (0.05)
Lag 1 (30 min) –0.04 (0.04) –0.04 (0.04)
Lag 2 (60 min) –0.02 (0.04) –0.02 (0.04)
Lag 3 (90 min) –0.002 (0.04) –0.004 (0.04)
Lag 4 (120 min) 0.02 (0.04) 0.02 (0.04)
Lag 5 (150 min) 0.04 (0.04) 0.04 (0.04)
Lag 6 (180 min) 0.06 (0.04) 0.06 (0.04)
Lag 7 (210 min) 0.09 (0.05)* 0.09 (0.05)*
Cumulative 0.11 (0.25) 0.09 (0.25)
QRS duration (msec)
Lag 0 (same time) –0.002 (0.014) –0.002 (0.014)
Lag 1 (30 min) 0.001 (0.009) 0.001 (0.009)
Lag 2 (60 min) 0.002 (0.012) 0.002 (0.012)
Lag 3 (90 min) –0.001 (0.015) –0.001 (0.015)
Lag 4 (120 min) –0.005 (0.016) –0.005 (0.016)
Lag 5 (150 min) –0.012 (0.017) –0.012 (0.017)
Lag 6 (180 min) –0.021 (0.019) –0.021 (0.019)
Lag 7 (210 min) –0.033 (0.026) –0.032 (0.026)
Cumulative –0.070 (0.092) –0.068 (0.092)
aModel 1 adjusted for age, sex, race, temperature, and 
relative humidity. bModel 2 adjusted for model 1 covari-
ables, plus diabetes, hypertension, and CVD. *p < 0.05. 
**p < 0.01.PM2.5 negatively affects ventricular repolarization
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Results
The demographic and CVD risk profiles of 
the study population are presented in Table 1. 
The mean age of the participants was 56 years 
old, 74% were non­Hispanic white, 26% 
were minorities (including blacks, Hispanics, 
and Chinese), 59% were female, and 43% 
had chronic diseases (mostly hypertension). 
Nine individuals (8.5%) reported being diag­
nosed with coronary heart disease by a physi­
cian > 2 years ago. At the population level, the 
distributions of both the PM2.5 exposure and 
ventricular repolarization outcome variables 
are approximately normal. The time of the 
day­specific distributions of the PM2.5 and 
QTI, as an example of ventricular repolari­
zation measures, are presented in Figures 1 
and 2, respectively. Both the PM2.5 and QTI 
showed sufficient variations, both between 
time points and between individuals, within 
the 24­hr time frame.
The cumulative effects and individual lag 
effects of PM2.5 on each of the HR­corrected 
QT measures and QRS duration are sum­
marized in Table 2 as multivariable adjusted 
regression coefficients (± SE) associated with 
a 10­µg/m3 increment of PM2.5 exposure. 
In summary, the cumulative effect based 
on lag 0–lag 7 (3.5 hr) on QTI was signifi­
cant (p < 0.01). Examining the individual 
lag effects, most of the adverse ventricular 
repolarization effects from direct PM2.5 expo­
sure occurred around 3–3.5 hr (lag 6–lag 7) 
after the elevation of PM2.5. The multivari­
able adjusted regression coefficients for the 
association between a 10­µg/m3 increase in 
PM2.5 and QTI were also statistically signifi­
cant at lag 0 and lag 1, suggesting both very 
early­ and later­phase responses. Additional 
adjustment for chronic disease did not change 
the pattern of association from the models 
adjusted only for major demographic and 
weather­related variables. PM2.5 was not asso­
ciated with QRS duration in this population 
(Table 2).
The final multivariable adjusted PM2.5 and 
QT measures (model 2) in Table 2 were rerun 
with additional adjustment for HRV variables, 
using one HRV variable at a time. The HRV­
adjusted PM2.5 and QT associations are pre­
sented in Table 3. In summary, the overall 
pattern of associations between PM2.5 and 
HR­corrected QT interval measures did not 
change substantially with additional adjust­
ment for HRV variables as measures of car­
diac autonomic modulation. However, the 
estimated lag 7 PM2.5 effects on QTI were 
attenuated, and the p­values from this lag 
were marginally significant (corresponding 
p­values were > 0.05 but < 0.10). To examine 
the potential confounding by the circadian 
variations of both QT variables and the PM2.5 
exposures, we also stratified our final mod­
els (model 2) as daytime versus nighttime for 
ECG measures (using 2100 hours as a cut 
off). These stratified models indicated similar 
patterns of association as those from the 24­hr 
overall models (data not shown).
We tested the interaction terms between 
PM2.5 and chronic conditions and found no 
statistical significance at p < 0.05 level (data 
not shown). Therefore, the estimated effects 
of PM2.5 on ventricular repolarization meas­
ures did not differ significantly depending on 
whether a person had previous health prob­
lems. We also performed stratified analysis 
according to chronic disease status, using the 
models in Table 2, model 1. We found simi­
lar associations by chronic disease status (data 
not shown). It should be noted that the sam­
ple size of this study is small, and individuals 
with chronic conditions consisted mostly of 
well­controlled hypertensives. The statistical 
power was limited to detect significant effect 
modification by chronic disease status.
Discussion
A large number of epidemiologic studies have 
found an association between short­term 
exposure to increased particulate air pol­
lution and CVD morbidity and mortality 
(Franklin et al. 2007, 2008; Ostro et al. 2006; 
Zanobetti and Schwartz 2009). However, the 
mechanisms responsible for such an associa­
tion have not been fully identified. Previous 
studies have suggested several promising 
underlying mechanisms, including cardiac 
autonomic impairment as measured by lower 
HRV (Creason et al. 2001; Gold et al. 2000; 
Liao et al. 1999, 2004; Pope et al. 1999), 
and ventricular repolarization (Campen et al. 
2006; Ghelfi et al. 2008; Henneberger et al. 
2005; Lux and Pope 2009; Samet et al. 2009; 
Yue et al. 2007). Various studies, including 
patient­based population, panel study, large 
population­based cohort, controlled expo­
sures, or ambient fixed­location air pollution 
measures, have indirectly suggested short­
term PM effects on cardiac electrophysiology 
and clinically relevant arrhythmias (Dockery 
et al. 2005; Elder et al. 2007; Liao et al. 1999, 
2004, 2009; Lux and Pope 2009; Park et al. 
2005; Yue et al. 2007; Zanobetti et al. 2009; 
Zhang et al. 2009); these cardiac parameters 
Figure 1. Time-specific PM2.5 exposure (mean ± SD) over 24 hr in the APACR study.
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Figure 2. Time-specific QTI (mean ± SD) over 24 hr in the APACR study.
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included HRV, ventricular repolarization, 
T­wave alternans, myocardium ischemia, and 
arrhythmias. The actual time course from PM 
exposure to effects on cardiac repolarization 
measures has not been investigated system­
atically in a community­dwelling sample, nor 
has it been determined whether the PM and 
ventricular repolarization association would be 
mediated through its impact on cardiac auto­
nomic modulation. Cavallari et al. reported an 
early­ and a later­phase HRV response, with 
the early effects at 2 hr and delayed effects at 
9–13 hr after exposure (Cavallari et al. 2008).
For the healthy individuals in this com­
munity­based study, PM2.5 had a significant 
adverse association with ventricular repolariza­
tion, regardless of which HR­corrected QT 
intervals were used. Specifically, the estimated 
cumulative effects of PM2.5 on QTI were sta­
tistically significant, and the direction of point 
estimates from the other two HR­corrected 
QTs (QtcB and QTcF) indicated the same 
anticipated direction as QTI, although the 
estimated cumulative effects for these latter 
two QTs were not significant at the p < 0.05 
level. For the individual lag effects, all three 
QT meas  ures were consistently associated with 
PM2.5 exposures at lag 6 and lag 7 (approxi­
mately 3–3.5 hr after elevated PM2.5), with 
the estimated effect on QTI also showing evi­
dence of an earlier­phase effect (lag 0 and lag 
1, approximately within 1 hr of PM exposure 
elevation). We did not find any association 
between PM2.5 and QRS duration. Therefore, 
these data support that elevated PM2.5 levels 
can lead to longer ventricular repolarization 
but have no immediate impact on ventricular 
depolarization (QRS duration). The appar­
ent effect courses within 3–3.5 hr of elevated 
PM2.5 exposure. The results presented in 
Table 3 indicate that the PM and QT and 
PM–QRS association remains unchanged, even 
after adjusting for HRV variables as potential 
intermediating factors. These data further sug­
gest that the PM2.5 and ventricular repolari­
zation measures were not mediated through 
adverse effects on cardiac autonomic modula­
tion, at least not effects with the same lag from 
exposure. Furthermore, the time from exposure 
to apparent effects was approximately 3–3.5 hr. 
Considered with other studies that have indi­
cated shorter­term acute PM effects on cardiac 
electrophysiology and arrhythmias, our current 
time­course study results are consistent with 
previous studies and are suggestive of an acute 
PM2.5­mediated disturbance of the ventricular 
repolarization process, which may contribute 
to acute cardiac events, particularly arrhyth­
mias and sudden cardiac death. To our knowl­
edge, this is the first study to demonstrate such 
findings in a community­based sample.
A number of approaches have been devel­
oped to estimate ventricular repolarization 
including the HR­corrected QT intervals 
that we used in this study—QTI, QTcB, and 
QTcF. We used these three HR­corrected 
QT measures because QTcB is the first 
HR­corrected QT index, and QTcF has simi­
lar properties but better HR correction com­
pared with QTcB. Both QTcB and QTcF 
are widely used in the literature. We also 
used the less frequently seen QTI because it 
was reported to be less sensitive to changes 
in HR and more repeatable than QTcB 
(Rautaharju et al. 1991). On the other hand, 
it was suggested that these HR­corrected 
QT measures should not be used to deter­
mine the treatment effects in patients with 
QT­prolongation syndrome (Rautaharju et al. 
2009). However, this study sample repre­
sents community­dwelling individuals, and 
none have long QT syndrome. In effect, we 
designed this study to investigate the impact 
of PM on the variation of HR­corrected QT 
intervals within normal range in relatively 
healthy individuals. Moreover, these simple 
HR­corrected QT variations among normal 
healthy individuals have been associated with 
significant prediction of future risk of cardiac 
events (Rautaharju et al. 2006a, 2006b), sup­
portive of our use of these indices.
It should be noted that the effect sizes we 
estimated in this study are relatively small. 
For example, for every 10­µg /m3 increase in 
PM2.5, the associated cumulative increase in 
QTI from previous 3.5 hr is only 0.32, cor­
responding to less than a 1% increase in this 
variable, which has a mean of 110 and SD of 
6.6. For another instance, for every 10­µg /m3 
increase in lag 7 PM2.5, the associated increase 
in QTcB is only 0.22 msec, corresponding to 
less than a 1% increase in this variable, which 
has a mean of 438 msec and SD of 23 msec. 
Although such small changes in QTI may not 
be clinically meaningful, it can be argued that 
the entire population is exposed to PM2.5 in 
the ambient air, and from personal and indoor 
sources, on a continuous daily basis. Thus, 
elevated PM2.5 levels have a potentially large 
public health impact. Moreover, the minor 
effect on QTI estimated in this study was 
measured in generally healthy individuals. It 
is possible that PM2.5 effects on ventricular 
repolarization might be greater in individu­
als with underlying structural heart disease, 
ischemic heart disease, channelopathies, or 
drug­induced effects on repolarization. Future 
studies should target these clinical subgroups 
likely to be more susceptible to the effects of 
PM2.5, especially those made more vulnerable 
by residing near sources of PM2.5, for example, 
near highways.
There are several limitations. First, the 
APACR study excluded smokers and per­
sons with acute cardiac events within the past 
6 months. Thus, our findings may not apply to 
smokers or persons with a recent acute cardiac 
event. Second, the majority of participants 
reported that they stayed indoors most of the 
time during the 24­hr study period, except 
when they had to travel by automobile. This 
behavior pattern is reflected in the relatively 
low levels of exposure to PM2.5. In general, 
our participants had limited indoor expo­
sures, such as secondhand smoking. Thus, 
we were unable to assess whether exposures at 
much higher levels would exhibit similar asso­
ciations. However, we purposely used the per­
sonal monitors and real­time Holter system 
to collect the true individual level exposure 
and routine ECG data, respectively. We argue 
that the associations we observed in these 
individuals are more reflective of their routine 
exposure and outcome associations. Third, 
the ECG data from Holter were not collected 
under a controlled, supine­position setting. 
Thus, the short­term variation of other factors 
that may impact the ventricular repolarization 
cannot be fully accounted for. However, it is 
not feasible to keep a healthy participant in a 
supine indoor position for 24 hr. Even if this 
were achieved, the results from such a study 
design would likely have limited variation 
in PM2.5 exposure levels, and the data from 
such a study would not be generalizable to a 
real­world situation. In contrast, our study 
captures the range of activities occurring in 
real life, including time spent outdoors, time 
spent commuting in an automobile, and vari­
ous other activities associated with a disease­
free, community­dwelling individual. Finally, 
PM2.5 was the only pollutant on which data 
were collected. The observed associations 
could be due to other unmeasured pollutants 
highly correlated with PM2.5.
In summary, acute exposure to PM2.5 at 
the individual level is associated with longer 
HR­corrected QT interval measures, and the 
time to the apparent effect is about 3–3.5 
hr. The estimated effect of PM on ventricu­
lar repolarization was independent of major 
confounding factors and cannot be attributed 
solely to effects of PM on cardiac autonomic 
modulation (HRV). There was no association 
between PM2.5 and QRS duration, suggest­
ing no effects on ventricular depolarization. 
Overall, these findings support that PM may 
affect ventricular repolarization, and partly 
through such a mechanism, PM increases car­
diovascular risk, such as sudden cardiac death.
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